- Filed
- May 2, 2014 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2014 · Apr 24, 2014 | 76.49M sh |
| Operating Cash Flow | Q1 2014 · Mar 31, 2014 | $59.1M |
| Operating Cash Flow restated | Q1 2014 · Mar 31, 2013 | −$43.2M |
| Long Term Debt | Q1 2014 · Mar 31, 2014 | $1.19B |
| Long Term Debt | Q1 2014 · Dec 31, 2013 | $1.25B |
| Short Term Debt | Q1 2014 · Mar 31, 2014 | $45.7M |
| Short Term Debt | Q1 2014 · Dec 31, 2013 | $40.1M |
| Stockholders Equity | Q1 2014 · Mar 31, 2014 | $1.32B |
| Stockholders Equity | Q1 2014 · Dec 31, 2013 | $1.3B |
| Current Liabilities | Q1 2014 · Mar 31, 2014 | $945.4M |
| Current Liabilities | Q1 2014 · Dec 31, 2013 | $969.8M |
| Total Liabilities | Q1 2014 · Mar 31, 2014 | $2.35B |
| Total Liabilities | Q1 2014 · Dec 31, 2013 | $2.44B |
| Current Assets | Q1 2014 · Mar 31, 2014 | $1.66B |
| Current Assets | Q1 2014 · Dec 31, 2013 | $1.74B |
| Total Assets | Q1 2014 · Mar 31, 2014 | $3.67B |
| Total Assets | Q1 2014 · Dec 31, 2013 | $3.74B |
| Shares Diluted | Q1 2014 · Mar 31, 2013 | 76.75M sh |
| Stock Repurchased | Q1 2014 · Mar 31, 2013 | $1.5M |
| Capex | Q1 2014 · Mar 31, 2013 | $19.9M |
| Cash And Equivalents | Q1 2014 · Mar 31, 2013 | $157M |
| Cash And Equivalents | Q1 2014 · Dec 31, 2012 | $122.8M |
| Eps Diluted | Q1 2014 · Mar 31, 2013 | $0.43 |
| Eps Basic | Q1 2014 · Mar 31, 2013 | $0.43 |
| Sga Expense | Q1 2014 · Mar 31, 2013 | $96.2M |
| Rd Expense | Q1 2014 · Mar 31, 2013 | $10.3M |
| Net Income | Q1 2014 · Mar 31, 2013 | $32.9M |
| Operating Income | Q1 2014 · Mar 31, 2013 | $65.5M |
| Gross Profit | Q1 2014 · Mar 31, 2013 | $172M |
| Cost Of Revenue | Q1 2014 · Mar 31, 2013 | $594.4M |
| Revenue | Q1 2014 · Mar 31, 2013 | $766.4M |